Due to growing public awareness of sexually transmitted illnesses and the existence of major market participants in the U.K. and Germany, growth expectations for Europe remain optimistic. According to FMI’s research, the North American genital herpes treatment market will account for around 34.3% of the global market by 2021 as a result of increased genital herpes prevalence in the U.S. and rising healthcare expenditure in the area.
NEWARK, Del: As per Future Market Insights’ latest industry analysis, the valuation for the According to the market projections given in the report, global Genital Herpes Treatment Market is expected to surge and reach a market size of over US$ 2881.8 Million by the end of 2031. The market is expected to register a CAGR of 4.5% of during the forecast period of 2021 to 2031.
Genital herpes is a common sexually transmitted disease. With the increase in population of various regions, there is also an increase in the rate of health issues around the world. As the rate of diseases grow, the treatment markets are also expected to grow substantially.
With respect to sexually transmitted disease like genital herpes, its treatment market includes different drug types like Acyclovir, Valacyclovir and Famciclovir. The indication of genital herpes include HSV-1 and HSV-2.
Request Sample Report @
The market growth is primarily driven by the increase government spending on healthcare industry. Various countries are focused on prevention of infectious diseases which in turn, has a positive impact over the herpes drugs market leading to its high demand from local governments and third-party payers.
Global Genital Herpes Treatment Market: Trends and Opportunities
The global genital herpes treatment market may witness new opportunities in the market. Globally, the increasing disease burden of herpes continuously provides an opportunity for the diagnostic and treatment market.
According to WHO, in 2016 around 67% of the world population (3.7 Bn) under the age of 50 were suffering from HSV-1 infection. This represents substantial growth of the global HSV disease treatment market over the forecast period. Similarly around 13% of the world population (491 Mn) under the age of 50 is living with HSV-2 infection as of 2016.
The companies are also trying to introduce cost effective treatment methods. New vaccines provide complete protection against a variety of strains of HSV1 and HSV2. Companies are increasing research and development activities for the treatment and prevention of genital herpes diseases. Most of the companies are focusing on approval and launch of generic drugs in the undeveloped countries to provide low cost drugs for the treatment of genital herpes.
Ask An Analyst @
Global Genital Herpes Treatment Market: Key Highlights from the Segmental Analysis
MEA is expected to come up as the most lucrative region in the industry. With the rise in sexually transmitted diseases in the region, the demand for genital herpes treatment is also expected to rise.
Regional analysis shows that MEA will witness a robust CAGR of 5.2% during the forecast period in the global genital herpes treatment market. Based on the route of administration oral is the main segment, with the highest growth rate and highest market share in the global genital herpes treatment market.
Amongst various distribution channels, retail pharmacies hold the highest market size, but the segment lags behind in terms of growth rate. With the growth of online marketing and e-commerce, online pharmacies is the fastest growing segment which is expected to register a growth rate of 5.4% during the forecast period.
Global Genital Herpes Treatment Market: Top Companies
Some of the leading companies mentioned in the research report are Teva Pharmaceutical Industries Ltd., Abbott Laboratories, Sun Pharmaceuticals Industries Ltd., Mylan N.V., Pfizer Inc., GlaxoSmithKline plc., Dr. Reddy’s Laboratories, ltd., Novartis AG, Valeant Pharmaceuticals International Inc., etc.
Ask for Customization @
Key Segments Covered in Genital herpes treatment Market Study
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Drug Stores
Route of Administration:
Key Regions/Countries Covered:
- North America
- Latin America
- Western Europe
- Eastern Europe
- Asia Pacific Ex. Japan (APEJ)
- Middle East & Africa
Read Full Report @
Table of Content
- Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
1.4. Wheel of Fortune
- Market Introduction
2.1. Market Taxonomy
2.2. Market Definition
- Genital Herpes Treatment Market View Point
3.1. Macro-Economic Factors
3.2. Opportunity Analysis
Explore FMI’s Extensive Coverage On Healthcare Domain:
Non-Invasive Blood Glucose Monitoring Devices Market Size : Non-Invasive Blood Glucose Monitoring Devices Market – Global industry segment analysis, regional outlook, share, growth; non-invasive blood glucose monitoring devices market forecast 2017 to 2027 by future market insights.
Pharmacy And Drug Store Franchises Market Demand : The market for pharmacies and drugstore franchises is predicted to expand by approximately 14% year over year to reach US$ 82.4 billion in 2023, up from US$ 72 billion in 2022. Also, a CAGR of 14.2% is predicted for the market from 2023 to 2033, leading to a valuation of US$ 310.87 billion.
Aesthetic Medicine And Cosmetic Surgery Market Share : In the end of 2021, the market for aesthetic medicine and cosmetic surgery was worth around US$ 67.4 Billion. By 2032, the market is anticipated to grow at a rate of 11.7% CAGR and reach a value of US$ 137.2 billion.
Milking Equipment Market Analysis : By 2023’s end, the market for milking equipment is projected to reach a value pool of $4 billion. The market for milking equipment is anticipated to increase globally, reaching US$ 7 billion in 2033 at a CAGR of 5.8%.
Key Opinion Leader Management Market Growth : A CAGR of 12.5% is expected of the global key opinion leader management market, due to the growing demand during the forecast period. It is anticipated to be appraised at US$ 211.27 Billion by 2032, up from US$ 65.06 Billion in 2022.
About Future Market Insights, Inc :
Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
LinkedIn | Twitter | Blogs | YouTube
For Sales Enquiries: firstname.lastname@example.org
Link Source @ https://www.globenewswire.com/fr/news-release/2018/02/27/1395972/0/en/Genital-Herpes-Treatment-Market-is-expected-to-register-a-CAGR-of-4-4-of-during-the-Forecast-Period-of-2017-2027.html